Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Bioadaptives (BDPT) Gross Profit (2019 - 2025)

Bioadaptives' Gross Profit history spans 7 years, with the latest figure at $7583.0 for Q4 2025.

  • Quarterly results put Gross Profit at $7583.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $12497.0 (up 210.1% YoY), and the annual figure for FY2025 was $12497.0, up 210.1%.
  • Gross Profit for Q4 2025 was $7583.0 at Bioadaptives, up from $3851.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $7583.0 in Q4 2025 to a low of $429.0 in Q2 2024.
  • The 5-year median for Gross Profit is $2153.0 (2022), against an average of $2622.2.
  • The sharpest move saw Gross Profit surged 2180.27% in 2021, then crashed 71.21% in 2024.
  • Year by year, Gross Profit stood at $1142.0 in 2021, then dropped by 9.81% to $1030.0 in 2022, then skyrocketed by 162.04% to $2699.0 in 2023, then crashed by 84.11% to $429.0 in 2024, then soared by 1667.6% to $7583.0 in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $7583.0, $3851.0, and $1063.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.